Ireland· IE-PA-EU/1/19/1420/001
Recarbrio 500 mg/500 mg/250 mg powder for solution for infusion
A imipenem, cilastatin and relebactam product containing imipenem + cilastatin + relebactam, registered in Ireland by Merck Sharp & Dohme BV,. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Imipenem, cilastatin and relebactam is registered in 11 of 19 countries.
Countries holding a registration under ATC J01DH56 (imipenem, cilastatin and relebactam), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Imipenem, cilastatin and relebactam · ATC J01DH56
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Imipenem + Cilastatin + Relebactam
- Manufacturer
- Merck Sharp & Dohme BV,
- Country
- Ireland (IE)
- ATC code
- J01DH56
- ATC class
- Imipenem, cilastatin and relebactam
- Defined daily dose
- 2 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/19/1420/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imipenem, cilastatin and relebactam in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayRecarbrioMSD
- SpainRECARBRIO 500 mg/500 mg/250 mg POLVO PARA SOLUCION PARA PERFUSIONMerck Sharp & Dohme B.V.
- FinlandRecarbrioMerck Sharp & Dohme B.V.
- FranceRECARBRIO 500 mg/500 mg/250 mg, poudre pour solution pour perfusionMERCK SHARP & DOHME (PAYS-BAS)
- United KingdomRecarbrio 500mg/500mg/250mg powder for solution for infusion vialsMerck Sharp & Dohme (UK) Ltd
- NetherlandsRecarbrio 500 mg/500 mg/250 mg, poeder voor oplossing voor infusieMerck Sharp & Dohme B.V.
- SwedenRecarbrio 500 mg/500 mg/250 mg Pulver till infusionsvätska, lösningMerck Sharp & Dohme BV
- CzechiaRECARBRIOMerck Sharp & Dohme B.V., Haarlem
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Recarbrio
- Liechtenstein · Recarbrio
- Norway · Recarbrio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dcf64746-21dc-402d-b3a6-397294939aef GET /v1/drugs/dcf64746-21dc-402d-b3a6-397294939aef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"J01DH56"
],
"strength": null,
"pa_number": "EU/1/19/1420/001",
"substances": [
"Imipenem",
"Cilastatin",
"Relebactam"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "13/02/2020",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about imipenem, cilastatin and relebactam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.